Luoxin Pharmaceuticals Group Stock Co Ltd (002793) - Total Assets

Latest as of September 2025: CN¥3.99 Billion CNY ≈ $583.88 Million USD

Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) holds total assets worth CN¥3.99 Billion CNY (≈ $583.88 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Luoxin Pharmaceuticals Group Stock Co Lt (002793) shareholders funds for net asset value and shareholders' equity analysis.

Luoxin Pharmaceuticals Group Stock Co Ltd - Total Assets Trend (2011–2024)

This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's total assets have evolved over time, based on quarterly financial data.

Luoxin Pharmaceuticals Group Stock Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Luoxin Pharmaceuticals Group Stock Co Ltd's total assets of CN¥3.99 Billion consist of 41.2% current assets and 58.9% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	10.5%
Accounts Receivable	CN¥662.93 Million	15.3%
Inventory	CN¥459.56 Million	10.6%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥674.40 Million	15.6%
Goodwill	CN¥1.95 Million	0.1%

Asset Composition Trend (2011–2024)

This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 002793 market cap overview.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Luoxin Pharmaceuticals Group Stock Co Ltd's current assets represent 41.2% of total assets in 2024, a decrease from 75.2% in 2011.
Cash Position: Cash and equivalents constituted 10.5% of total assets in 2024, down from 24.0% in 2011.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 2.0% in 2011.
Asset Diversification: The largest asset category is intangible assets at 15.6% of total assets.

Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Total Assets

Key competitors of Luoxin Pharmaceuticals Group Stock Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥31.46 Billion
Yuhan Corp. KO:000100	Korea	₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	China	CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion

Luoxin Pharmaceuticals Group Stock Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.81	0.85	1.65
Quick Ratio	0.64	0.63	1.43
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥-384.24 Million	CN¥-363.12 Million	CN¥1.91 Billion

Luoxin Pharmaceuticals Group Stock Co Ltd - Advanced Valuation Insights

This section examines the relationship between Luoxin Pharmaceuticals Group Stock Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.80
Latest Market Cap to Assets Ratio	0.20
Asset Growth Rate (YoY)	-15.3%
Total Assets	CN¥4.34 Billion
Market Capitalization	$880.09 Million USD

Valuation Analysis

Below Book Valuation: The market values Luoxin Pharmaceuticals Group Stock Co Ltd's assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Luoxin Pharmaceuticals Group Stock Co Ltd's assets decreased by 15.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2024)

The table below shows the annual total assets of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥4.34 Billion ≈ $634.49 Million	-15.27%
2023-12-31	CN¥5.12 Billion ≈ $748.84 Million	-36.88%
2022-12-31	CN¥8.11 Billion ≈ $1.19 Billion	-14.63%
2021-12-31	CN¥9.50 Billion ≈ $1.39 Billion	+22.99%
2020-12-31	CN¥7.72 Billion ≈ $1.13 Billion	+3.50%
2019-12-31	CN¥7.46 Billion ≈ $1.09 Billion	+432.24%
2018-12-31	CN¥1.40 Billion ≈ $205.12 Million	+55.93%
2017-12-31	CN¥898.93 Million ≈ $131.54 Million	+10.58%
2016-12-31	CN¥812.89 Million ≈ $118.95 Million	+47.91%
2015-12-31	CN¥549.60 Million ≈ $80.42 Million	+22.72%
2014-12-31	CN¥447.86 Million ≈ $65.54 Million	+23.28%
2013-12-31	CN¥363.30 Million ≈ $53.16 Million	-2.42%
2012-12-31	CN¥372.31 Million ≈ $54.48 Million	+36.91%
2011-12-31	CN¥271.94 Million ≈ $39.79 Million	--

About Luoxin Pharmaceuticals Group Stock Co Ltd

SHE:002793 China Drug Manufacturers - Specialty & Generic

Market Cap

$880.09 Million

CN¥6.01 Billion CNY

Market Cap Rank

#9688 Global

#2713 in China

Share Price

CN¥5.53

Change (1 day)

+2.60%

52-Week Range

CN¥4.25 - CN¥6.50

All Time High

CN¥25.07